Sanatela: Working to assist Covid-19 pneumonia treatment/cure clinical trial

https://wefunder.com/sanatelalifesciencesinc

We have been asked to do a quick pivot to produce MSC stem cells, from Wharton's jelly that is found inside the umbilical cord of healthy births, from a research use to a treatment use.

We have the potential to produce trillions of MSC's for treatment and potential cure for Covid-19 severe pneumonic. These cells would be infused by the billions following the basic methodology used in the Beijing clinical trial that produced tremendous results in a small but highly skilled clinical trial.

There are currently three firms working very hard to complete a fast-track clinical trial of this procedure that shows so much promise.

It is very odd for me to watch President Trump promote a drug used for malaria and lupus as the solution to this pandemic when the logical focus should be upon the actual clinical trial completed from China.

We are working to get our labs rolling and producing MSCs in the fairly likely event that the stem cell clinical trails are as successful as anticipated. We filed for at Covid-19 program with Wefunder and the Federal Government.

It is my view that MSCs have the potential to do many wonderful things for mankind. It is more than about time that we stop being so afraid of stem cell treatments and simply do the work required to validate use or to prove that the treatment doesn't work.

I wonder when President Trump will realize that there is a lot more value in stem cell treatment potential for Covid-19 victims - focus attention on this treatment and we will see some amazing results from what I understand.

To learn more about how we use MSCs and Decellurized Wharton's jelly tissue, go to www.sanatelamedical.com. We have a great explainer video on the home page. Also see Sanatela Matrix Launch Video on YouTube.https://www.youtube.com/watch?v=XD34QkJTIcI